Spots Global Cancer Trial Database for bone pain
Every month we try and update this database with for bone pain cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid | NCT00172029 | Breast Cancer W... | Zoledronic acid | 18 Years - | Novartis | |
| Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid | NCT00172029 | Breast Cancer W... | Zoledronic acid | 18 Years - | Novartis | |
| Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain | NCT03407430 | Breast Cancer Lymphoma Pain | Pregabalin Placebo | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain | NCT03407430 | Breast Cancer Lymphoma Pain | Pregabalin Placebo | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer | NCT01522443 | Prostate Cancer Castration Resi... Pain Prostatic Neopl... | cabozantinib mitoxantrone prednisone | 18 Years - | Exelixis | |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 | NCT03102606 | Chemotherapy-in... | Plinabulin Pegfilgrastim Saline Placebo D5W Placebo | 18 Years - | BeyondSpring Pharmaceuticals Inc. | |
| Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy | NCT00972959 | Multiple Myelom... | Bortezomib Zoledronic Acid Dexamethasone | 18 Years - | University of Athens | |
| Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone | NCT03529565 | Bone Pain Breast Carcinom... | Biospecimen Col... Laboratory Biom... Quality-of-Life... Questionnaire A... | 18 Years - | Wake Forest University Health Sciences | |
| Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer | NCT01522443 | Prostate Cancer Castration Resi... Pain Prostatic Neopl... | cabozantinib mitoxantrone prednisone | 18 Years - | Exelixis | |
| Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia | NCT03294577 | Chemotherapy-in... | Pegfilgrastim Plinabulin D5W Placebo Docetaxel, doxo... | 18 Years - | BeyondSpring Pharmaceuticals Inc. | |
| Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma | NCT03858205 | Bone Pain Metastatic Mali... Plasma Cell Mye... | Quality-of-Life... Questionnaire A... Radiation Thera... | 18 Years - | University of Southern California | |
| Pain Management Support Study for Patients With Advanced Cancer | NCT03432247 | Advanced Cancer | Interactive Mus... Verbal support | 18 Years - | Drexel University | |
| Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets | NCT03661892 | Bone Metastases Breast Cancer Pain | Syndros | 21 Years - | University of Arizona | |
| Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 | NCT01605227 | Prostate Cancer Castration Resi... Pain Prostatic Neopl... | cabozantinib prednisone | 18 Years - | Exelixis | |
| Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy | NCT00972959 | Multiple Myelom... | Bortezomib Zoledronic Acid Dexamethasone | 18 Years - | University of Athens | |
| NOLAN: Naproxen or Loratadine and Neulasta | NCT01712009 | Bone Pain in St... | Naproxen Loratadine Pegfilgrastim Chemotherapy | 18 Years - 100 Years | Amgen | |
| Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy | NCT05753618 | Early-stage Bre... | Granulocyte Col... Omission of Gra... | 18 Years - | Ottawa Hospital Research Institute | |
| Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer | NCT01847976 | Pain | Doxycycline | 19 Years - | Ottawa Hospital Research Institute | |
| Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim | NCT01752907 | Breast Cancer | General Educati... Bone Pain Educa... | 18 Years - 99 Years | Amgen | |
| Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets | NCT03661892 | Bone Metastases Breast Cancer Pain | Syndros | 21 Years - | University of Arizona | |
| Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma | NCT03858205 | Bone Pain Metastatic Mali... Plasma Cell Mye... | Quality-of-Life... Questionnaire A... Radiation Thera... | 18 Years - | University of Southern California | |
| Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid | NCT00172029 | Breast Cancer W... | Zoledronic acid | 18 Years - | Novartis | |
| Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone | NCT00609934 | Renal Cell Carc... | Sorafenib external beam r... | 18 Years - | University Health Network, Toronto | |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 | NCT03102606 | Chemotherapy-in... | Plinabulin Pegfilgrastim Saline Placebo D5W Placebo | 18 Years - | BeyondSpring Pharmaceuticals Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
